Trikafta is expected to be a “game-changing” therapy for cystic fibrosis (CF), especially for younger patients, say researchers at Children’s Hospital of Richmond at Virginia Commonwealth University (VCU), who were involved in Trikafta trials where marked improvements were seen in patients taking the therapy.
Source: Trikafta Will Be ‘Life-Transforming,’ Especially for Younger CF Patients, Researchers Say